RBC disorder Flashcards
anemia
reduction in red cell mass, with consequent decrease in oxygen transport capacity of the blood.
what are the clinical parameters used in testing for anemia?
red cell count, hemoglobin concentration, and hematocrit, all of which reflect, but do not directly measure, the red cell mass. Accepted “normal” levels vary with age, sex, and geographic location.
clinical manifestations of anemia
results in impaired tissue oxygenation as manifest by exertional shortness of breath, weakness, fatigue, and pallor. Polycythemia denotes an increase in red cell mass.
how can anemias be classified?
Anemias can be classified into three broad categories based on the mechanism by which red cell mass is decreased: blood loss, decreased red cell production, and decreased red cell survival. Other classification systems based on red cell morphology are also in common use.
•RBC loss
–Hemorrhage (acute and chronic)
•Decreased RBC survival
–Hemolysis
•Decreased RBC production
–Nutritional deficiencies, aplastic anemia, myelophthistic processes
what laboratory tests are done for anemia?
•CBC –RBC count –Hemoglobin –Hematocrit –Mean cell volume (MCV), Hb (MCH), and Hb concentration (MCHC) –WBC –Platelets •Blood smear review •Reticulocyte count
•Iron Indices
–serum Fe, iron-binding capacity, transferrin saturation, ferritin concentration
–Vitamin B12 and folate (serum and RBC concentrations)
Hemolysis work-up •Bilirubin –direct and indirect •Haptoglobin •LDH •Coomb’s test •Plasma hemoglobin •Hemoglobin electrophoresis
red blood cell loss
Young healthy subjects can tolerate rapid loss of 500-1000 mL (up to 15-20% of total blood volume) with few symptoms, but some will have a vasovagal response- sweating, weakness, nausea, slow heart rate, hypotension. If blood loss is controlled, interstitial fluid will redistribute (within 24 hours) into the vascular space in an attempt to re-expand the vascular volume. Loss of 1000-1500 mL produces lightheadedness, orthostatic hypotension; with loss of 1500-2000 mL, all patients are symptomatic- thirst, shortness of breath, loss of consciousness, sweating, rapid pulse, decreased blood pressure, clammy skin. Rapid loss of 2000-2500 mL produces shock. The loss of RBC stimulates increased production, mediated by erythropoietin, resulting in an increase in the reticulocyte count in the peripheral blood.
chronic blood loss
causes anemia when the rate of loss exceeds the capacity for RBC regeneration or when iron reserves are depleted. Chronic GI hemorrhage due to ulcer or neoplasm, or GYN hemorrhage (menorrhagia) are important causes of iron deficiency.
hemolytic anemias
characterized by shortened red cell survival and retention of products of red cell destruction (iron). Increased erythropoietin production results in increased red cell production with a reticulocytosis to compensate for the anemia. Red cell destruction can occur within the circulation (intravascular hemolysis) or in the reticuloendothelial system including spleen (extravascular hemolysis).
what is intravascular hemolysis?
: destruction of RBC within the circulation. Examples: -mechanical trauma (e.g., from a defective heart valve), hemolytic transfusion reaction. Hemoglobin released from RBC into circulation (hemoglobinemia) is bound to haptoglobin, a binding protein, and cleared from the circulation by the liver. A decrease in serum haptoglobin is a key feature of intravascular hemolysis. When plasma hemoglobin levels exceed amount of available haptoglobin, free hemoglobin is excreted in the urine (hemoglobinuria); however hemoglobin is toxic to the kidney, and iron that accumulates in proximal tubular cells in the kidney as a breakdown product of hemoglobin is lost in the urine when these cells are shed (hemosiderinuria). Conversion of heme (derived from hemoglobin) to bilirubin leads to hyperbilirubinemia and jaundice. The degree of jaundice is dependent on the functional capacity of the liver and rate of hemolysis. Levels of haptoglobin are characteristically low.
•Immune-
–Transfusion reaction
•Non-immune-
–Mechanical trauma (defective heart valve)
•Decreased haptoglobin, hemoglobinemia, hemoglobinuria, hemosiderinuria, hyperbilirubinemia, reticulocytosis
what is extravascular hemolysis?
destruction of RBC in reticuloendothelial system (spleen, liver). Examples: Hereditary spherocytosis, sickle cell anemia, erythroblastosis fetalis (antibody-mediated hemolytic disease of the newborn). Damaged or abnormal RBC are removed in spleen, where hemoglobin is broken down intracellularly. Free hemoglobin is not released directly into the blood and urine, but hemoglobin breakdown products are increased (hyperbilirubinemia) and jaundice may result. Spleen and liver may become enlarged since these are sites of removal of RBC from the circulation. Chronically elevated levels of bilirubin can promote formation of gallstones.
•Immune - Extrinsic defects
–Autoimmune
–Erythroblastosis fetalis
–Transfusion reaction
•Non-immune - Intrinsic defects –RBC membrane defects –Hemoglobinopathies –Metabolic defects •Decreased haptoglobin, hyperbilirubinemia, reticulocytosis •May have hepatosplenomegaly
how is hemolytic anemias classified?
Hemolytic anemias are classified by the mechanism of red cell destruction into intrinsic defects (hemoglobin production, membrane abnormality) which are usually inherited, and extrinsic defects (antibody, mechanical trauma) which are usually acquired abnormalities.
what is hereditary spherocytosis?
membrane defect
intrinsic defect
– extravascular hemolysis.
An inherited defect in the red cell membrane results in less deformability of RBC, so that they are sequestered and destroyed in the spleen. The specific defect can be a qualitative or quantitative deficiency of spectrin, a structural protein of the cytoskeleton. Autosomal dominant inheritance in most cases. Manifest in adult life, severity is variable. Removal of spleen results in normal red cell survival but not normal red cell morphology. Production of spherocytes continues, but following splenectomy their destruction is decreased.
–Abnormality of spectrin, a structural protein of the red cell cytoskeleton
–RBC’s are less deformable – can’t squeeze through the splenic sinusoids, thus are sequestered and destroyed in the spleen
–Splenectomy helps symptoms and anemia
–Red cells remain abnormal (spheres)
what is sickle cell anemia?
abnormal hemoglobin
intrinsic defect
extravascular hemolysis
An inherited defect (autosomal codominant) in the structure of globin chain causes hemoglobin to gel upon deoxygenation. The specific defect is a single base pair substitution in DNA that causes a single amino acid substitution (valine for glutamic acid) at position 6 in the beta chain of globin to produce sickle hemoglobin (HbS). Under low oxygen conditions the abnormal hemoglobin polymerizes, causing the RBC to assume a “sickle” shape. The sickled cells are rigid and vulnerable to splenic sequestration (decreased survival), and can also block the microcirculation causing ischemia and/or infarction. Sickle cell disease occurs in homozygotes for HbS, and is characterized by severe anemia, and vaso-occlusive crises, including acute chest syndrome and stroke. Complications may also include autosplenectomy, painful crises, leg ulcers, retinal and renal thromboses. About 8% of blacks in USA have sickle cell trait (heterozygotes), and are essentially asymptomatic because less than half of the hemoglobin is abnormal and the concentration of HbS within the RBC is insufficient to cause sickling. Small but significant resistance to malaria.
•Moderate to severe anemia •Hyperbilirubinemia, reticulocytosis •“Autosplenectomy” •Sickle Cell Trait –Heterozygotes; Hemoglobin AS –Clinically asymptomatic –Sickle cells are absent
what is thalassemia?
lack of globin chains
intrinsic defect
extravascular hemolysis
. An inherited defect (autosomal codominant) that results in diminished or absent synthesis of either the alpha or beta globin chains of hemoglobin. The cause at the gene level can include whole or partial gene deletion, mutations in the coding sequence or promotor region, or mRNA instability. The type of thalassemia is named for the globin chain produced in reduced amounts. Decreased globin production results in decreased hemoglobin production, and anemia is the principal clinical manifestation. In addition, precipitation of the relative excess of the other globin chain within RBC causes membrane damage and premature destruction of RBC precursors in the marrow and spleen (ineffective erythropoiesis and extravascular hemolysis). Clinical manifestations vary from severe transfusion-dependent anemia and iron overload (thalassemia major) to mild anemia (thalassemia minor). In almost all cases there is a moderate to marked microcytosis (low MCV) with target cells and basophilic stippling of the red cells present on the blood smear. As the severity of the anemia increases there is increasing abnormalities of red cell shapes and sizes. Thalassemia is relatively common in persons of Mediterranean, African, and Southeast Asian descent. Reduces impact of malaria.
what is Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency ?
metabolic defect
intrinsic defect
extravascular hemolysis. An inherited defect (X-linked) encountered primarily in blacks in which red cells are susceptible to oxidant injury by drugs or toxins (antimalarials, sulfonamides, etc.). The denaturation of oxidized hemoglobin causes it to precipitate within the cell and attach to the RBC membrane. The RBC membrane’s flexibility is reduced, leading to extravascular hemolysis. The condition is asymptomatic in the absence of the oxidant.
•“Bite” cells are the morphologic hallmark on cytologic exam